Global Summit and Award Ceremonies
For Cancer Research & Entrepreneurship
Saturday, October 22, 2022
Co-Hosted by
Thank you for your interest in our Global Summit. Though this year’s event has concluded, all sessions will be availble for viewing in our Oncology Metaverse. Click below to join our virtual community.
Select a Session Below to View the Agenda
Summit Overview
Saturday, Oct. 22
Part I
New Frontiers for Cancer Research
8:45 am -12:25 pm
8:45 – 8:55 am
Welcome and Opening Remarks
Sujuan Ba, Ph.D., CEO of NFCR, Co-Founder of AIM-HI, & Founder of AFCR
Session I: Molecular Approaches to Understand and Treat Cancer
8:55 – 10:30 am
Moderator: Web Cavenee, Ph.D., Chair of NFCR Scientific Advisory Board; Distinguished Professor of Medicine, University of California, San Diego and Director of Strategic Alliances, Ludwig Institute for Cancer Research
Panel Members:
- Ken C. Anderson, M.D., Dana-Farber Cancer Institute, Professor of Medicine, Harvard; Physician Oncology, Brigham and Women’s Hospital
- J. Silvio Gutkind Ph.D., Professor and Chair, Pharmacology, University of California, San Diego
- Aaron N. Hata, M.D., Ph.D., Assistant Professor of Medicine, Harvard
- Isidore Rigoutsos, Ph.D., Professor in Computational Medicine, Thomas Jefferson University
- Suzanne Topalian, M.D., Professor of Oncology and Surgery, Johns Hopkins University
- Katherine Uyhazi, M.D., Ph.D., Assistant Professor of Ophthalmology, University of Pennsylvania
10:30 -10:45 am: Coffee Break
Session II: New Approaches to Treat Breast, Pancreatic, and Head & Neck Cancer
10:45 am – 12:20 pm
Moderator: Jennifer Grandis, M.D., American Cancer Society Professor of Otolaryngology, University of California, San Francisco
Panel Members:
- Lisa Coussens, Ph.D., Professor and Chair, Department of Cell, Developmental & Cancer Biology, Oregon Health and Sciences University
- Daniel A. Haber, M.D., Ph.D., Director, Massachusetts General Hospital Cancer Center
- Courtney Houchen, M.D., Professor, Chief of Digestive Diseases and Nutrition, Oklahoma University School of Medicine
- Daniel E. Johnson, Ph.D., Professor and Vice Chair of Research, Otolaryngology and Head and Neck Surgery, University of California, San Francisco
- Kornelia Polyak, M.D., Ph.D., Professor of Medicine, Dana-Farber Cancer Institute, Harvard
- Xiang-Lei Yang, Ph.D., Professor of Molecular Biology and Medicine, Scripps Research
12:20 – 12:25 pm
Closing Remarks:
Alfred Slanetz, Ph.D. Chairman of Board of Directors, NFCR; CEO of Geneius Biotechnology
Part II
Luncheon Award Ceremony for
Entrepreneurship & Women’s Leadership
12:30-2:00 pm
Emcee: Rose Wang, MBA, Executive Advisor of AIM-HI Accelerator Fund
Introduction of the AIM-HI Leadership & Entrepreneurship program:
Sujuan Ba, Ph.D., CEO & Co-Founder of AIM-HI Accelerator Fund
Award Presentation of the AIM-HI Beacon Award for Women Leaders in Oncology
- Overview of the Beacon Award Selection Process: Web Cavenee, Ph.D., Co-Chair of the Selection Committee of the Beacon Award
- Introduction of the Awardee: Janet Woodcock, M.D., Principal Deputy Commissioner of the U.S. Food and Drug Administration
- Presenting the Beacon Award Medallion to the Recipient by the Award Selection Committee Members
2022 Beacon Award Winner Award Speech: Anna Barker, Ph.D., Chief Strategy Officer of Ellison Institute for Transformative Medicine
Award Presentation of the Top Finalists for the 2022 Women’s Venture Competition & 2022 BRACE Award Venture Competition: Pamela Garzone, Ph.D., Co-Chair of the Competition Selection & Judging Committees; Chief Development Officer of Anixa Biosciences
Women’s Venture Competition: Dimitra Georganopoulou, Ph.D., Co-Chair of the Competition Investment Committee; General Partner of Qral Ventures
- Johanna Webb, President of RiverWalk Therapeutics
- Revital Mandil-Levin, Ph.D., CEO & Co-Founder of Nanocarry Therapeutics
- Rosa Hwang, M.D., Co-Founder of Stellanova Therapeutics
BRACE Award Venture Competition: Beverly Lu, Ph.D., Co-Chair of the Competition Investment Committee; Investment Manager, Health of Emerson Collective
- Li Chai, M.D., Co-Founder of Believer Pharmaceuticals
- Rajiv Datar, Ph.D., Co-Founder & CEO of Propelle Therapeutics
Closing Remarks: Rose Wang, MBA, Executive Advisor of AIM-HI Accelerator Fund
2:00-2:15 pm: Coffee Break
Part III
AIM-HI Select Portfolio Companies Showcase
2:15-4:00 pm
Welcome and Opening Remarks:
Sujuan Ba, Ph.D., CEO of NFCR, Co-Founder of AIM-HI, & Founder of AFCR
Presentation:
- Lora Green, Ph.D., J.D., Partner, Patents & Innovations, Wilson Sonsini Goodrich & Rosati:
- Critical Intellectual Property Protection Strategies & Common Pitfalls for Early-stage Companies
Panel Discussion: Opportunities & Challenges Facing Leadership of Early-stage Oncology Companies
Moderator: Raju Kucherlapati, Ph.D., Harvard Medical School
Panel Members:
- Paul Finn, Ph.D., CSO of Oxford Drug Design Limited
- Pritesh Gandhi, PharmD, CEO of TellBio
- Vlad Hogenhuis, M.D., MBA, CEO of Chimera Bioengineering
- John Luk, DMedSc, EMBA, CEO of Arbele Bio
- Ken Malone, Ph.D., CEO of Rasio Therapeutics
- María Varela, CEO of Ardan Pharma
Closing Remarks:
Charlie Weatherspoon, Chair of the Board of the Director, AIM-HI Accelerator Fund
4:00-6:00 pm: Intermission
Part IV
2022 Szent-Györgyi Prize Dinner & Award Ceremony
Black Tie Optional
6:00 – 7:00 pm
Cocktail Reception
7:00 – 8:30 pm
Dinner Award Ceremony
Moment of Silence
Opening and Welcome Remarks: Sujuan Ba, Ph.D., CEO of NFCR, Co-Founder of AIM-HI, & Founder of AFCR; Co-Chair of the 2022 Selection Committee for the Szent-Györgyi Prize
Introduction of the 2022 Szent-Györgyi Prize Winner:
Doug Lowy, M.D., 2018 Szent-Györgyi Prize Winner; Principal Deputy Director of the U.S. National Cancer Institute
Award Trophy Presentation:
Dr. Sujuan Ba, Co-Chair of the 2022 Selection Committee for the Szent-Györgyi Prize
2022 Szent-Györgyi Prize Winner Award Speech:
Rakesh K. Jain, Ph.D., Andrew Werk Cook Professor of Radiation Oncology, Harvard Medical School; Director, Edwin L. Steele Laboratories for Tumor Biology, Massachusetts General Hospital
SPECIAL THANKS TO OUR SPONSORS!
Sponsorship Opportunities
Inquiries regarding sponsorship of our Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship event can be made by e-mail at Sponsorship@nfcr.org or by phone at 1-800-321-CURE (2873).
“The Women’s Leadership Forum was spectacular and the chemistry between all of the people on the podium and the energy was wonderful. It was inspirational to all and especially young women who were there and might have been watching.”
-Dr. Raju Kucherlapati, Paul C. Cabot Professor of Genetics, Harvard Medical School and 2021 Precision Medicine in Cancer Panel Moderator
“Absolutely wonderful, inspirational meeting…thanks so much to everyone involved and to NFCR for making it possible for us to get together. I am grateful to be included!”
-Monica Bertagnolli, M.D., Professor, Surgery, Harvard Medical School, Former President of American Society of Clinical Oncology (ASCO), and 2021 Women’s Leadership Panel Participant
Special Thanks To Our 2021 Sponsors!
Click here to see details about the sessions of our 2021 Global Summit.
All sessions from our 2021 Gobal Summit are now available on-demand on our Oncology Metaverse. 2022 Virtual participants will also be able to join the meeting from here.
Why Should You Attend This Event?
- Be inspired by world-renowned speakers on the latest landscape change of translational cancer research
- Actively engage in thought-provoking discussions with key opinion leaders
- Personally interact with award-winning pioneer scientists and join the celebration for their breakthrough cancer discoveries